https://www.processapharmaceuticals.com/news-media/presentations/rss en-us https://d1io3yog0oux5.cloudfront.net/processapharmaceuticals/files/theme/images/logo-sm.png https://www.processapharmaceuticals.com Equisolve Investor Relations Suite https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10325/pdf/Processa+General+Investor+Presentation+March+2025.pdf Fri, 28 Mar 25 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10325/pdf/Processa+General+Investor+Presentation+March+2025.pdf https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10322/pdf/Processa+General+Investor+Presentation+02112025+Final.pdf Tue, 11 Feb 25 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10322/pdf/Processa+General+Investor+Presentation+02112025+Final.pdf https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10317/pdf/Processa+General+Investor+Presentation+August+2024.pdf Mon, 26 Aug 24 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10317/pdf/Processa+General+Investor+Presentation+August+2024.pdf https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10300/pdf/Processa+General+Investor+Presentation+03282024+Final+%28003%29.pdf Wed, 03 Apr 24 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10300/pdf/Processa+General+Investor+Presentation+03282024+Final+%28003%29.pdf https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10296/pdf/Processa+General+Investor+Presentation+2-19-24.pdf Fri, 01 Mar 24 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10296/pdf/Processa+General+Investor+Presentation+2-19-24.pdf https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10293/pdf/Processa+General+Investor+Presentation+01082024+Final+.pdf Thu, 11 Jan 24 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10293/pdf/Processa+General+Investor+Presentation+01082024+Final+.pdf https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10289/pdf/Processa+Pharmaceuticals+MedInvest+December+2023_David+Young_Final_12052023.pdf Tue, 05 Dec 23 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10289/pdf/Processa+Pharmaceuticals+MedInvest+December+2023_David+Young_Final_12052023.pdf https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10286/pdf/20th+Orphan+Drugs+%26+Rare+Disease+November+16+2023+Boston_Final_David+Young.pdf Thu, 16 Nov 23 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10286/pdf/20th+Orphan+Drugs+%26+Rare+Disease+November+16+2023+Boston_Final_David+Young.pdf https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10282/pdf/Processa+Corporate+Presentation+20231108.pdf Fri, 10 Nov 23 00:00:00 -0500 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10282/pdf/Processa+Corporate+Presentation+20231108.pdf https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10268/pdf/Processa+Pharmaceuticals+MedInvest+June+21+2023_David+Young.pdf Wed, 21 Jun 23 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_a2b1e5cb446af5c9402e2ba7b1eb1893/processapharmaceuticals/db/1085/10268/pdf/Processa+Pharmaceuticals+MedInvest+June+21+2023_David+Young.pdf